News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TetraLogic Pharmaceuticals (TLOG) To Present Data From Its Clinical Investigation Of SHAPE At The Annual Society Of Investigative Dermatology Meeting


5/5/2014 9:24:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MALVERN, Pa., May 5, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that data from the phase 1 randomized, placebo-controlled clinical study of SHAPE (formerly SHP-141) in Stage IA –IIA Cutaneous T Cell Lymphoma will be presented at the annual Society of Investigative Dermatology Meeting to be held in Albuquerque, New Mexico from May 7– May 10, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES